APONVIE, an aprepitant product, highlighted as the only FDA-approved IV formulation Neurokinin-1 ("NK-1”) antagonist indicated for the prevention of PONV in adults, with a long half-life and quicker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback